{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:10:41Z","timestamp":1790230241098,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01EY036417"],"award-info":[{"award-number":["R01EY036417"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01EY027749"],"award-info":[{"award-number":["R01EY027749"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R24EY028764"],"award-info":[{"award-number":["R24EY028764"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R43EY031238"],"award-info":[{"award-number":["R43EY031238"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R43EY032827"],"award-info":[{"award-number":["R43EY032827"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R21EY035421"],"award-info":[{"award-number":["R21EY035421"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R44EY027665"],"award-info":[{"award-number":["R44EY027665"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>We developed ligandomics for the in vivo profiling of vascular ligands in mice, discovering secretogranin III (Scg3) as a novel angiogenic factor that selectively binds to retinal vessels of diabetic but not healthy mice. This discovery led to the development of anti-Scg3 therapy for ocular vasculopathies. However, in vivo ligandomics requires intracardial perfusion to remove unbound phage clones, limiting its use to vascular endothelial cells (ECs). To extend ligandomics to non-vascular cells, we investigated ex vivo ligandomics. We isolated ECs and retinal ganglion cells (RGCs) from diabetic and healthy mouse retinas by immunopanning. We quantified the binding of clonal phages displaying Scg3 and vascular endothelial growth factor (VEGF), confirming that their binding patterns to isolated diabetic versus healthy ECs matched in vivo patterns. Additionally, Scg3 and VEGF binding to isolated RGCs reflected their in vivo activity. These results support the feasibility of ex vivo ligandomics. We further mapped ligands binding to immunopanned diabetic and healthy ECs and RGCs by ligandomics, confirming that Scg3 was enriched with selective binding to diabetic ECs but not healthy ECs or diabetic\/healthy RGCs. These findings demonstrate the feasibility of ex vivo ligandomics, which can be broadly applied to various cell types, tissues, diseases, and species.<\/jats:p>","DOI":"10.3390\/biom15010145","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:04:12Z","timestamp":1737345852000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of Ex Vivo Ligandomics"],"prefix":"10.3390","volume":"15","author":[{"given":"Prabuddha","family":"Waduge","sequence":"first","affiliation":[{"name":"Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7374-8146","authenticated-orcid":false,"given":"Remya Ammassam","family":"Veettil","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-5931","authenticated-orcid":false,"given":"Bojun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchi","family":"Huang","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[{"name":"LigandomicsRx, LLC, Houston, TX 77098, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8764","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Combarnous, Y., and Nguyen, T.M.D. (2020). Cell Communications among Microorganisms, Plants, and Animals: Origin, Evolution, and Interplays. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202008.0379.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cbpa.2017.03.010","article-title":"Targeting ligand-receptor interactions for development of cancer therapeutics","volume":"38","author":"Kim","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_3","first-page":"RE9","article-title":"Signaling receptome: A genomic and evolutionary perspective of plasma membrane receptors involved in signal transduction","volume":"187","author":"Hsu","year":"2003","journal-title":"Sci. STKE"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20161802","article-title":"Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy","volume":"214","author":"LeBlanc","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103430","DOI":"10.1016\/j.drudis.2022.103430","article-title":"Profiling disease-selective drug targets: From proteomics to ligandomics","volume":"28","author":"Waduge","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1111\/febs.16356","article-title":"Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization","volume":"289","author":"Ji","year":"2022","journal-title":"FEBS J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10456-019-09662-4","article-title":"Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety","volume":"22","author":"Tang","year":"2019","journal-title":"Angiogenesis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00018-021-04111-2","article-title":"Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy","volume":"79","author":"Dai","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single dose streptozotocin-induced diabetes: Considerations for study design in islet transplantation models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab. Anim."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ji, L., Waduge, P., Wu, Y., Huang, C., Kaur, A., Oliveira, P., Tian, H., Zhang, J., Stout, J.T., and Weng, C.Y. (2023). Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310531"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e22106","DOI":"10.1096\/fj.202101085RR","article-title":"Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization","volume":"36","author":"Ji","year":"2022","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huang, C., Waduge, P., Kaur, A., Tian, H., Weng, C.Y., Stout, J.T., Pang, I.-H., Webster, K.A., and Li, W. (2024). Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179507"},{"key":"ref_13","first-page":"165","article-title":"Comparative Ligandomic Analysis of Human Lung Epithelial Cells Exposed to PM 2.5","volume":"33","author":"Tian","year":"2020","journal-title":"Biomed. Environ. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-013-1779-3","article-title":"PECAM-1: Regulator of endothelial junctional integrity","volume":"355","author":"Privratsky","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chintalapudi, S.R., Djenderedjian, L., Stiemke, A.B., Steinle, J.J., Jablonski, M.M., and Morales-Tirado, V.M. (2016). Isolation and Molecular Profiling of Primary Mouse Retinal Ganglion Cells: Comparison of Phenotypes from Healthy and Glaucomatous Retinas. Front. Aging Neurosci., 8.","DOI":"10.3389\/fnagi.2016.00093"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Waduge, P., Kaur, A., and Li, W. (2024). A method for rapid and reliable quantification of VEGF-cell binding activity. Biochem. Biophys. Res. Commun., 727.","DOI":"10.1016\/j.bbrc.2024.150321"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1046\/j.0953-816X.2000.01326.x","article-title":"Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor","volume":"12","author":"Sondell","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.drudis.2018.01.013","article-title":"Ligandomics: A paradigm shift in biological drug discovery","volume":"23","author":"Li","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exer.2019.03.009","article-title":"Function-first ligandomics for ocular vascular research and drug target discovery","volume":"182","author":"Rong","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, Y., Tian, H., Dai, C., Wen, R., Li, X., Webster, K.A., and Li, W. (2021). Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010350"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Richards, A.L., Eckhardt, M., and Krogan, N.J. (2021). Mass spectrometry-based protein-protein interaction networks for the study of human diseases. Mol. Syst. Biol., 17.","DOI":"10.15252\/msb.20188792"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-98758-3_3","article-title":"Proteomics in Systems Biology","volume":"1102","author":"Aizat","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2024","journal-title":"Nat. Protoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cels.2022.03.001","article-title":"Ligand-receptor promiscuity enables cellular addressing","volume":"13","author":"Su","year":"2022","journal-title":"Cell Syst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.molcel.2019.05.030","article-title":"PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression","volume":"75","author":"Sendinc","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Mol. Cell Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/j.1460-2075.1990.tb08123.x","article-title":"Genetic ablation of a mouse gene expressed specifically in brain","volume":"9","author":"Kingsley","year":"1990","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ICO.0000000000001871","article-title":"Effect of Anti-Vascular Endothelial Growth Factor Therapy on Corneal Nerves","volume":"38","author":"Goldhardt","year":"2019","journal-title":"Cornea"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Arima, M., Akiyama, M., Fujiwara, K., Mori, Y., Inoue, H., Seki, E., Nakama, T., Tsukamoto, S., Ochiai, M., and Ohga, S. (2020). Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230678"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2011.05.028","article-title":"Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons","volume":"71","author":"Vong","year":"2011","journal-title":"Neuron"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cyto.a.23690","article-title":"Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry","volume":"95","author":"Reichard","year":"2019","journal-title":"Cytom. A"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/1\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:31:17Z","timestamp":1759919477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/1\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["biom15010145"],"URL":"https:\/\/doi.org\/10.3390\/biom15010145","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]}}}